Quoin Pharmaceuticals, Ltd.

US$3.65As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:QNRXHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (85.59%)
Div yield —
ROE (142.54%)
Biotechnology
Beta (5Y) 1.64
PE TTM —
TSR TTM (67.70%)
Mkt cap US$17.54M
ROIC (78.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.87
6.05%
(90.06%)
Buy 2|0|3|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.05
12.70%
(1.29%)
8.36%
22.98%
Revenue$M
0.981
1.036
1.091
1.124
(1.90%)
2.50%
10.73%
11.32%
Peers (US$17.54M)
Cap (US$)
PE
17.91M
—
Capital
TTM
5Y
10Y
Leveragex
5.179
(0.049)
(0.036)
EBIT/Intx
0.784
0.086
0.126
Own earn%
(49.66)
141.91
96.45
Sh yield%
9.92
5.57
6.56
Owners
Insiders/Inst%
14.13
85.96
Short interest%
3.33
SBC / revenue%
2.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
5–11
$1 testx
—
Incr. ROIC%
27